* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : allergy and immunology;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/ponesimod
2024
false
false
false
France
French
risk management
ponesimod
ponesimod
administration, oral
ponesimod
ponvory
guidelines for drug use
patients guideline
pregnancy
continuity of patient care
ponesimod
adult
multiple sclerosis, relapsing-remitting
drug monitoring
immunosuppressive agents
immunosuppressive agents
immunosuppressive agents

---
https://ansm.sante.fr/tableau-acces-derogatoire/yescarta-0-4-2-x-108-cellules-dispersion-pour-perfusion#
2024
false
false
false
France
French
axicabtagene ciloleucel
axicabtagene ciloleucel
biological products
Antineoplastic Agents, Immunological
Recurrent High Grade B-Cell Lymphoma
lymphoma, large B-Cell, diffuse
adult
Refractory High Grade B-Cell Lymphoma
drug information
immunotherapy, adoptive
antigens, CD19

---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide

---
https://ansm.sante.fr/tableau-marr/pomalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide

---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet

---
https://www.cochrane.org/fr/CD011381/MS_quels-sont-les-benefices-et-les-risques-des-medicaments-agissant-sur-le-systeme-immunitaire-pour
2024
false
false
false
France
United Kingdom
review of literature
french abstract
Immunomodulators
immunosuppressive agents
multiple sclerosis, nos
Network Meta-Analysis
immunomodulators
Multiple sclerosis
multiple sclerosis, relapsing-remitting
multiple sclerosis
immunologic factors

---
https://ansm.sante.fr/actualites/abrogation-de-certaines-autorisations-de-mise-sur-le-marche-de-generiques-de-tecfidera
2024
false
false
false
France
French
drug information
drugs, generic
Dimethyl Fumarate
legislation, pharmacy
europe
drug approval
dimethyl fumarate
legislation, drug

---
https://www.has-sante.fr/jcms/p_3483264/fr/fluenz-tetra-vaccin-grippal-quadrivalent-vivant-attenue-nasal-vaccin-antigrippal
2024
false
false
false
France
evaluation of the transparency committee
Trivalent Live-Attenuated Influenza Vaccine
preventive immunization/medication
Nasal Route of Administration
Trial Element Duration
Influenza Vaccine
influenza virus vaccine
vaccines, attenuated
Quadrivalent Influenza Vaccine
Nasal Dosage Form
vaccination
nose, nos
influenza vaccines
Tea Leaf
Ezatiostat Hydrochloride
attenuated by

---
https://www.has-sante.fr/jcms/p_3487097/fr/columvi-glofitamab-lymphome-diffus-a-grande-cellule-b-ldgcb
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
infusions, intravenous
Antineoplastic Agents, Immunological
lymphoma, large B-Cell, diffuse
Recurrent Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
glofitamab
evaluation of the transparency committee
glofitamab

---
https://ansm.sante.fr/tableau-marr/inhibiteur-de-la-c1-esterase-humaine
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
Human C1-Esterase Inhibitor
patients guideline

---
https://ansm.sante.fr/tableau-marr/ranibizumab-2
2024
false
false
false
France
French
Ranibizumab
byooviz
drug information
patient education handout
risk management
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
intravitreal injections

---
https://www.has-sante.fr/jcms/p_3487904/fr/xolair-omalizumab-polypose-naso-sinusienne
2024
false
false
false
France
nasal polyps
Polyp of nasal cavity and/or nasal sinus (disorder)
evaluation of the transparency committee
xolair
Omalizumab
Polyposis
Omalizumab

---
https://www.has-sante.fr/jcms/p_3488174/fr/nplate-romiplostim-thrombopenie-immunologique-primaire-pti-refractaire-aux-autres-traitements
2024
false
false
false
France
Primary Immune Thrombocytopenia
evaluation of the transparency committee
nplate
principal
Romiplostim
Immunotherapy
romiplostim
Refractory
thrombocytopenia due to immune destruction, nos
Primary Refractory
romiplostim
idiopathic thrombocytopenic purpura, nos
Other Therapy
Immune
Immunology
thrombocytopenia
purpura, thrombocytopenic, idiopathic
immunology

---
https://esante.gouv.fr/produits-services/repertoire-ror
France
directory
Offer
Resource Guide
directories as topic
social support
socialism
Research Resource
Social
measles-mumps-rubella vaccine
health resources
Means

---
https://ansm.sante.fr/actualites/nouvelles-donnees-en-faveur-dun-risque-accru-de-saignements-menstruels-abondants-apres-la-primovaccination-contre-le-covid-19
2024
false
false
false
France
French
pharmacovigilance note
COVID-19 Vaccines
vaccination
COVID-19
mRNA Vaccines
Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
technical report
menorrhagia
covid-19, RNA-based vaccine
risk
risk assessment

---
https://www.has-sante.fr/jcms/p_3491589/fr/vivotif-salmonella-enterica-serovar-typhi-souche-ty21a-vaccin-anti-typhoidique-vivant-attenue
2024
France
evaluation of the transparency committee
salmonella typhi
Attenuated
vaccination
vaccination
preventive immunization/medication
vaccinia
salmonella typhi
attenuated by
typhoid vaccine
salmonella enterica
CDISC SEND Laboratory Animal Strain Terminology
Ty21a Typhoid Vaccine
Attenuation
SEND Test System Strain
vaccines
typhoid vaccination
Salmonella Serotype Typhi
Alive
typhoid-paratyphoid vaccines
Reside

---
https://www.santepubliquefrance.fr/presse/2024/impact-de-la-pollution-de-l-air-dans-les-etablissements-scolaires-sur-l-asthme-des-enfants-de-6-a-11-ans-sante-publique-france-presente-les-premi
2024
France
scientific and technical information
CHFR Gene
Impact
Smoking at Diagnosis
schools
Loss of Chromosome 11
Severity of Symptom Score 6
resulting in
Offspring
french
Six
public health
child, nos
Clinical Status Ordinal Scale Outcome 6
Arginine/Omega-3 Fatty Acids/Nucleotides Oral Supplement
Child
Air
Thought Score 6
asthma
Illness Intrusiveness Rating 6
Child Health
Autonomic Nervous System
Public Health
Fear Score 6
air pollution
Asthma
air pollution
Asthma Pathway
Eleven
asthma
Established
france
asthma, nos

---
https://publications.msss.gouv.qc.ca/msss/document-003690/
2024
Canada
handbooks
Guide Device
Medical Examination
Radiation Boost
complement system proteins
symptom assessment
Handbook
Digital Mammography
mammography, nos
mammography
CDISC SDTM Medical Evaluator Identifier Terminology

---
https://iris.who.int/handle/10665/375750
2024
Switzerland
journal article
Implementation
Nicotine Lozenge
vaccination
Consultation
vaccination
September
vaccinia virus vaccine
group processes
Reunion
advisory committees
preventive immunization/medication
Meeting
Vaccine Research
vaccines
Vaccination
research

---
https://ansm.sante.fr/tableau-acces-derogatoire/itraconazole
2024
false
false
false
France
French
itraconazole
guidelines for drug use
administration, oral
tinea
child
microsporum
antifungal agents
itraconazole
continuity of patient care

---
https://www.has-sante.fr/jcms/p_3415710/fr/strategie-de-vaccination-contre-la-covid-19-place-du-vaccin-comirnaty-bivalent-original/baba-4-5-10-g/dose-dans-la-strategie-de-rappel-des-enfants-de-5-a-11-ans-revolus-a-risque-de-forme-grave
2024
France
public health guidelines
Vaping
Offspring
Severity Four Out of Five
risk
Recollect
child, nos
severe
health planning guidelines
Eleven
COVID-19 Vaccines
Loss of Chromosome 11
vaccination
Callback
Reminder
Per Hundred Thousand
Bivalent Vaccines
Serious Risk
Recommendation
Strategy
Per Ten Thousand
Vaccination
Child
preventive immunization/medication
child
Vaccine
Placement
vaccination
Booster
vaccinia virus vaccine
Autonomic Nervous System

---
https://www.has-sante.fr/jcms/p_3494172/fr/avis-n-2024-001/ac/sespev-du-08-fevrier-2024-du-college-de-la-haute-autorite-de-sante-relatif-a-la-date-de-lancement-de-la-campagne-de-vaccination-au-printemps-2024-contre-la-covid-19
2024
France
scientific and technical information
Date Fruit
health
Vaccination
COVID-19 Infection
Newton
COVID-19
Spring
preventive immunization/medication
COVID-19 Vaccines
vaccination, nos
N Category
MATCH Arm EAY131-N
attitude to health
vaccination
Neither Agree or Disagree
No
N
Relative Value
vaccination
judgment
Regulatory Authority
College Completion
mass vaccination
Spring Device
Nano
February
schools
Signal to Noise Ratio
Tumor to Normal

---
https://ansm.sante.fr/tableau-marr/methotrexate-per-os
2024
false
false
false
France
French
guidelines for drug use
risk management
methotrexate
administration, oral
patient education handout
medication errors

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-fevrier-2024-5-8-fevrier
2024
false
false
false
France
French
pharmacovigilance note
nirmatrelvir and ritonavir drug combination
nirmatrelvir and ritonavir drug combination
immunosuppressive agents
drug therapy, combination
drug interactions

---
https://ansm.sante.fr/tableau-marr/adalimumab
2024
false
false
false
France
French
Adalimumab
risk management
continuity of patient care
drug information
adult
child
patient education handout

---
https://www.has-sante.fr/jcms/p_3495394/fr/takhzyro-lanadelumab-angioedeme-hereditaire
2024
false
false
false
France
French
insurance, health, reimbursement
lanadelumab
evaluation of the transparency committee
child
angioedemas, hereditary
Hereditary angioedema attack
lanadelumab
treatment outcome
guidelines for drug use
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)

---
https://www.has-sante.fr/jcms/p_3492882/fr/alvesco-ciclesonide-asthme
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
glucocorticoids
administration, inhalation
ciclesonide
evaluation of the transparency committee
asthma
ciclesonide

---
https://www.cmg.fr/wp-content/uploads/2024/02/CMG-Memo-vaccination-de-0-a-24-ans-actualise-fevrier.pdf
2024
France
scientific and technical information
Lansky Performance Status 0
Autonomic Nervous System
vaccination
methacryloxypropyltrimethoxysilane
Vaccination
Twenty Four
ECOG Performance Status 0
preventive immunization/medication
Synthetic Data
Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8
Angola
Severity of Symptom Score 0
Stage 0 Hilar Cholangiocarcinoma AJCC v8
vaccination, nos
vaccines, synthetic
Zero Full Term Pregnancies
Symptoms Extent Score 0
Splayed
Karnofsky Performance Status 0
dataset
Tumor Regression Score 0
Phase 0 Trial
Zero
Stage 0 Distal Bile Duct Cancer AJCC v8

---
https://www.cmg.fr/wp-content/uploads/2024/02/Memo-vaccin-25-CMG-2023-actualise-fevrier-2024.pdf
2024
France
scientific and technical information
methacryloxypropyltrimethoxysilane
Autonomic Nervous System
Splayed
vaccination
Vaccination
preventive immunization/medication
vaccines, synthetic
vaccination, nos
Twenty Five
Synthetic Data
dataset

---
https://minerva-ebp.be/FR/Article/2363
2024
Belgium
critical appraisal or critical reading
disease
disease, nos
Illinois
Useful
tretinoin
fatty acids, Omega-3
Autologous Anti-CD19/CD22 CAR T-cells AUTO3
Immune
vitamin D
Disease or Disorder
vitamin d, nos
Interleukin
fatty acid, nos
fatty acids
immune system diseases
What Month is it
Vitamin D Measurement
Ergocalciferol
Israel

---
https://www.has-sante.fr/jcms/p_3473151/fr/fiche-bum-dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2024
false
false
false
France
dupilumab
benralizumab
mepolizumab
tezepelumab
other systemic drugs for obstructive airway diseases
adult
child
drug therapy, combination
Severe persistent asthma (disorder)
adolescent
Respiratory corticosteroid (substance)
adrenergic beta-2 receptor agonists
guidelines for drug use
Omalizumab
asthma

---
https://www.has-sante.fr/jcms/p_3498562/fr/adtralza-tralokinumab-dermatite-atopique-chez-l-adulte-et-l-adolescent-a-partir-de-12-ans
2024
false
false
false
France
tralokinumab
injections, subcutaneous
adolescent
adult
dermatitis, atopic
Adult atopic dermatitis (disorder)
evaluation of the transparency committee
tralokinumab

---
https://www.has-sante.fr/jcms/p_3498741/fr/takhzyro-lanadelumab-angiooedeme-hereditaire
2024
false
false
false
France
antibodies, monoclonal, humanized
treatment outcome
insurance, health, reimbursement
angioedemas, hereditary
child
lanadelumab
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug)
Hereditary angioedema attack
evaluation of the transparency committee
lanadelumab

---
https://www.has-sante.fr/jcms/p_3498915/fr/recommandations-vaccinales-contre-le-zona-place-du-vaccin-shingrix
2024
France
public health guidelines
health planning guidelines
herpes zoster vaccine
herpes zoster, nos
vaccine, nos
Placement
Recommendation
Zoster Vaccine Recombinant, Adjuvanted
Shingles, CTCAE
herpes zoster
Vaccine Therapy
vaccination
Herpes Zoster
preventive immunization/medication

---
https://www.cochrane.org/fr/CD003962/RENAL_traitement-non-immunosuppresseur-dans-la-nephropathie-immunoglobulines
2024
United Kingdom
review of literature
french abstract
Nephropathy
Raw
IgA
kidney diseases
A^y/a
Immunoglobulin Therapy
immunoglobulin, nos
kidney disease, nos
immunosuppressive agents
Immunosuppressant
Intravenous Immunoglobulin Therapy
immunoglobulin A

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/protocole-medical-national-initier-un-test-immunochimique-de-recherche-de-sang-occulte-dans-les-selles-ou-une-coloscopie-a-des-fins-de-depistage-ou-de-diagnostic-du-cancer-colorectal.html
2024
Canada
public health guidelines
Test Name
immunochemistry
colonoscopy
On Study
screening for cancer
dermatomyositis
Colorectal Cancer
Cancer Diagnosis
biomedical research
Laboratory Procedure
Screening Colonoscopy
Test Dosing Unit
Screening for Colorectal Cancer
cancer screening
malignant neoplasm colon/rectum
early detection of cancer
Initiation
diagnosis
no diagnosis
Fecal Occult Blood Test
Blood Products Laboratory Testing
feces
screening for occult blood in feces
Clinical Study Protocol
medical research
colorectal neoplasms
occult blood

---
https://www.inrs.fr/media.html?refINRS=TF%20313
2024
France
journal article
Prevention Study
hypersensitivity reaction, nos
Have Allergy
Preventive Intervention
Implementation
Allergic Reaction
insect, nos
Insecta
animal husbandry
Prevention
hypersensitivity
Insect

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-de-mars-2024-4-7-mars
2024
false
false
false
France
French
drug information
mRNA Vaccines
COVID-19 Vaccines
Postmenopausal bleeding (finding)
pharmacovigilance

---
https://www.has-sante.fr/jcms/p_3500011/fr/bimzelx-bimekizumab-psoriasis-en-plaques
2024
France
evaluation of the transparency committee
psoriasis
bimekizumab
bimekizumab
bone plates
psoriasis vulgaris
Bimekizumab
Psoriasis
Patch

---
https://www.cochrane.org/fr/CD003216/WOUNDS_quels-sont-les-regimes-ou-les-complements-les-plus-efficaces-pour-prevenir-et-traiter-les-escarres
2024
United Kingdom
review of literature
french abstract
Treatment Regimen
pressure ulcer
complement system proteins
Basal Diet
Ethyl Glucuronide And Ethyl Sulfate Measurement
diet, nos
Treatment Factor
GDC Regimen Terminology
What Month is it
attentiveness
Dietary Supplement
Special Diet Therapy
eschar

---
https://www.has-sante.fr/jcms/p_3501621/fr/nuvaxovid-proteine-spike-de-sars-cov-2-et-un-adjuvant-matrix-m-covid-19
2024
France
evaluation of the transparency committee
MATRix Regimen
SARS Coronavirus
SARS-CoV-2
proteins
Zinc Finger FYVE Domain-Containing Protein 9
Adjudicator 2
spike protein, SARS-CoV-2
protein, nos
M Protein
adjuvant, nos
spike protein, SARS-CoV-2
M-2 protocol

---
https://www.has-sante.fr/jcms/p_3501630/fr/tepkinly-epcoritamab-lymphome-diffus-a-grande-cellule-b-ldgcb
2024
France
evaluation of the transparency committee
Murine Large Cell
Gastric Diffuse Adenocarcinoma
lymphoma, diffuse
B-Lymphocyte
lymphoma, large B-Cell, diffuse
Epcoritamab
b-lymphocytes
b lymphocyte
malignant lymphoma, nos
Childhood Lymphoma
Murine B-Lymphocytes
cells
Adult Lymphoma

---
https://ansm.sante.fr/informations-de-securite/paxlovid-nirmatrelvir-ritonavir-rappel-des-interactions-medicamenteuses-avec-certains-immunosuppresseurs-notamment-le-tacrolimus-pouvant-etre-fatales
2024
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
drug interactions
nirmatrelvir and ritonavir drug combination
nirmatrelvir
immunosuppressive agents
tacrolimus
COVID-19 Drug Treatment
adult
nirmatrelvir and ritonavir
tacrolimus

---
https://ansm.sante.fr/actualites/decision-du-21-03-2024-cadre-de-prescription-compassionnelle-de-tacrolimus-0-1-pommade
2024
false
false
false
France
French
drug information
tacrolimus
administration, cutaneous
ointments
legislation, pharmacy
adult
child
adolescent
vitiligo
tacrolimus

---
https://ansm.sante.fr/tableau-acces-derogatoire/tacrolimus#
2024
false
false
false
France
French
tacrolimus
drug information
administration, cutaneous
vitiligo

---
https://papyrus.bib.umontreal.ca/xmlui/handle/1866/32798
2024
Canada
dissertations, academic
attention
monoclonal antibody
Monoclonal Antibody
Apply
immunotherapy
immunotherapy, nos
Applicator
antibodies, monoclonal
Immunotherapy
Monoclonal Antibody (Therapeutic)
Apply

---
https://www.has-sante.fr/jcms/p_3505636/fr/rybrevant-amivantamab-cancer-bronchique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
carboplatin
amivantamab
Antineoplastic Agents, Immunological
bispecific monoclonal antibodies
advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
Activating EGFR Exon 20 Mutation
EGFR Exon 20 Insertion Mutation
Pemetrexed
adult
package leaflet
summary of product characteristics
guidelines for drug use
infusions, intravenous
evaluation of the transparency committee
bronchial neoplasms
amivantamab-vmjw

---
https://www.has-sante.fr/jcms/p_3503160/fr/zilbrysq-zilucoplan-sodique-myasthenie
2024
false
false
false
France
zilucoplan
treatment outcome
insurance, health, reimbursement
myasthenia gravis, generalized
myasthenia gravis
adult
Anti-acetylcholine receptor antibody positivity
evaluation of the transparency committee
zilucoplan
myasthenia gravis

---
https://ansm.sante.fr/tableau-marr/belatacept
2024
false
false
false
France
French
guidelines for drug use
risk management
BELATACEPT
immunosuppressive agents
infusions, intravenous
belatacept
patient education handout
Infusion-Related Reaction
infusions, intravenous

---
https://ansm.sante.fr/tableau-marr/sutimlimab
2024
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout

---
https://ansm.sante.fr/tableau-acces-derogatoire/blenrep
2024
false
false
false
France
French
infusions, intravenous
drug information
antibodies, monoclonal, humanized
belantamab mafodotin
Antineoplastic Agents, Immunological

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/equivalence-du-seuil-de-positivite-des-tests-immunochimiques-de-recherche-de-sang-occulte-dans-les-selles-pour-le-depistage-du-cancer-colorectal.html
2024
Canada
review of literature
feces
early detection of cancer
Equivalent
screening for occult blood in feces
cancer screening
screening for cancer
Research
Search
research
immunochemistry
Blood in Stool
colorectal neoplasms
Occult Blood Measurement
Colorectal Cancer
Screening for Colorectal Cancer
occult blood
Liquid Tumor
malignant neoplasm colon/rectum

---
https://ansm.sante.fr/tableau-marr/crizotinib
2024
false
false
false
France
French
patients guideline
patient education handout
drug information
risk management
Crizotinib
Crizotinib
continuity of patient care
crizotinib
vision disorders
adult
child

---
https://ansm.sante.fr/actualites/modification-des-conditions-de-prescription-et-de-delivrance-de-certaines-biotherapies-utilisees-dans-le-traitement-de-maladies-inflammatoires-chroniques
2024
false
false
false
France
French
guidelines for drug use
injections, subcutaneous
Interleukin Inhibitors
immunosuppressive agents
biological therapy
general practice
antibodies, monoclonal
immunoconjugates
Tumor Necrosis Factor Inhibitors
Chronic inflammatory disorder (disorder)

---
https://www.has-sante.fr/jcms/p_3506440/fr/repatha-evolocumab-hypercholesterolemie
2024
false
false
false
France
evaluation of the transparency committee
repatha
Hypercholesterolemia
hypercholesterolemia
evolocumab
Evolocumab
evolocumab
hypercholesterolemia, nos

---
https://ansm.sante.fr/actualites/rifampicine-conduites-a-tenir-dans-un-contexte-de-fortes-tensions-dapprovisionnement
2024
false
false
false
France
French
rifampin
france
administration, oral
infusions, intravenous
guidelines for drug use
antibiotics, antitubercular
-
-
-
osteoarticular infections
tuberculosis
Infection associated with device (disorder)
Infection associated with vascular device (disorder)
Staphylococcal endocarditis (disorder)

---
https://ansm.sante.fr/actualites/campagne-vaccinale-contre-les-infections-a-papillomavirus-humains-hpv-les-donnees-recueillies-apres-la-premiere-dose-confirment-le-profil-de-securite-du-vaccin-gardasil-9
2024
false
false
false
France
French
papillomavirus vaccines
papillomavirus infections
vaccine safety
Human Papillomavirus Recombinant Vaccine nonavalent
mass vaccination
Vaccination Campaign
technical report
adolescent
vaccination

---
https://ansm.sante.fr/actualites/point-de-situation-des-approvisionnements-en-auto-injecteurs-dadrenaline
2024
false
false
false
France
French
drug information
epinephrine
france
Epinephrine autoinjector (physical object)

---
https://www.has-sante.fr/jcms/p_3443053/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2
2024
false
false
false
France
adult
treatment outcome
insurance, health, reimbursement
Unresectable HER2-Positive Breast Carcinoma
Metastatic HER2-Positive Breast Carcinoma
neoplasm metastasis
trastuzumab deruxtecan
guidelines for drug use
Antineoplastic Agents, Immunological
infusions, intravenous
evaluation of the transparency committee
breast neoplasms
trastuzumab deruxtecan
Trastuzumab

---
https://ansm.sante.fr/tableau-acces-derogatoire/rybrevant
2024
false
false
false
France
French
summary of product characteristics
amivantamab-vmjw
Antineoplastic Agents, Immunological
amivantamab
advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations
carcinoma, non-small-cell lung
guidelines for drug use
package leaflet

---
https://ansm.sante.fr/tableau-acces-derogatoire/sotrovimab-500-mg-solution-a-diluer-pour-perfusion-intraveineuse-xevudy
2024
false
false
false
France
French
infusions, intravenous
drug information
adult
adolescent
COVID-19
sotrovimab
sotrovimab

---
https://www.has-sante.fr/jcms/p_3423139/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2024
false
false
false
France
Generalized pustular psoriasis
spesolimab
adult
treatment outcome
insurance, health, reimbursement
infusions, intravenous
evaluation of the transparency committee
psoriasis
spesolimab

---
https://ansm.sante.fr/tableau-acces-derogatoire/berinert-500-ui-mg-poudre-et-solvant-pour-solution-injectable-perfusion
2024
false
false
false
France
French
complement C1 inhibitor protein
guidelines for drug use
continuity of patient care
salvage therapy
graft rejection
Humoral rejection
heart transplantation
kidney transplantation
lung transplantation
infusions, intravenous
complement C1 inhibitor protein
technical report

---
https://ansm.sante.fr/tableau-marr/teclistamab
2024
false
false
false
France
French
popular works
drug information
Teclistamab
risk management
teclistamab

---
https://ansm.sante.fr/tableau-acces-derogatoire/adcetris-50-mg-poudre-pour-solution-a-diluer-pour-perfusion
2024
false
false
false
France
French
continuity of patient care
guideline
hodgkin disease
child
adolescent
adult
antineoplastic combined chemotherapy protocols
brentuximab vedotin
Brentuximab Vedotin
infusions, intravenous

---
https://ansm.sante.fr/actualites/nulojix-belatacept-pour-la-greffe-de-rein-recommandations-temporaires-pour-garantir-la-continuite-des-soins
2024
false
false
false
France
French
guidelines for drug use
Abatacept

---
https://ansm.sante.fr/tableau-marr/panobinostat
2024
false
false
false
France
French
risk management
Panobinostat
panobinostat
administration, oral
medication errors
patients guideline
patient compliance

---
https://ansm.sante.fr/tableau-marr/tacrolimus
2024
false
false
false
France
French
risk management
tacrolimus
tacrolimus
administration, oral
guidelines for drug use
patient education handout
continuity of patient care
immunosuppressive agents

---
https://ansm.sante.fr/tableau-marr/cladribine
2024
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests

---
https://ansm.sante.fr/tableau-marr/inebilizumab
2024
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection

---
https://ansm.sante.fr/tableau-marr/brolucizumab
2023
false
false
false
France
French
risk management
brolucizumab
intravitreal injections
patients guideline
drug information

---
https://ansm.sante.fr/tableau-acces-derogatoire/vyvgart
2023
false
false
false
France
French
efgartigimod alfa
infusions, intravenous
myasthenia gravis, generalized
Acetylcholine receptor antibody (substance)
Anti-acetylcholine receptor antibody positivity
efgartigimod alfa
generalised myasthenia gravis with anti-acetylcholine receptor antibody
drug information

---
https://ansm.sante.fr/tableau-acces-derogatoire/tezspire#
2023
false
false
false
France
French
tezepelumab
asthma
adult
adolescent
guidelines for drug use
evaluation of the transparency committee
continuity of patient care
injections, subcutaneous
forms
tezepelumab

---
https://ansm.sante.fr/tableau-acces-derogatoire/teclistamab
2023
false
false
false
France
French
drug information
Teclistamab
adult
multiple myeloma
Recurrent Multiple Myeloma
Refractory Multiple Myeloma
summary of product characteristics
package leaflet
antibodies, monoclonal
Antineoplastic Agents, Immunological
teclistamab

---
https://ansm.sante.fr/tableau-acces-derogatoire/enhertu-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
summary of product characteristics
package leaflet
guidelines for drug use
Metastatic Gastric Adenocarcinoma
stomach neoplasms
adenocarcinoma
neoplasm metastasis
Locally Advanced Gastric Adenocarcinoma
Metastatic Gastroesophageal Junction Adenocarcinoma
Locally Advanced Gastroesophageal Junction Adenocarcinoma
HER2/Neu Positive
trastuzumab deruxtecan
infusions, intravenous
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
breast neoplasms
Metastatic HER2-Positive Breast Carcinoma
Unresectable HER2-Positive Breast Carcinoma
Refractory HER2-Positive Breast Carcinoma
HER2-Low Breast Carcinoma
Metastatic HER2-Low Breast Carcinoma
neoplasm recurrence, local

---
https://ansm.sante.fr/tableau-marr/eculizumab
2023
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
drug monitoring
patient safety
sepsis
meningococcal infections
risk
vaccination
antibiotic prophylaxis
adult
child
infant
patients guideline
patient education handout

---
https://publications.msss.gouv.qc.ca/msss/document-000111/
2023
false
false
false
Canada
patient education handout
Vaccins
viral vaccines
Boys
vaccinia virus
type b viral hepatitis
Papilloma
vaccination
human papillomavirus, nos
Hepatitis
vaccinia virus
Vaccinia
daughters
Virus
hepatitis B
nuclear family
Human Papillomavirus Viruses
preventive immunization/medication
papillomaviridae
Viruses
principal
men

---
https://ansm.sante.fr/tableau-marr/fingolimod
2023
false
false
false
France
French
guidelines for drug use
patient education handout
Fingolimod Hydrochloride
pregnancy
administration, oral
immunosuppressive agents
immunosuppressive agents
fingolimod
continuity of patient care
Fingolimod Hydrochloride
teratogens
multiple sclerosis, relapsing-remitting
breast feeding
Fingolimod Hydrochloride
risk management

---
https://publications.msss.gouv.qc.ca/msss/document-003127/
2023
false
false
false
Canada
COVID-19
COVID-19 Vaccines
patients guideline
Vaccins
preventive immunization/medication
vaccine, nos
vaccination
vaccination, nos
health planning guidelines
Vaccinia
persons
vaccinia, nos
viral vaccines
coronavirus infections
travel

---
https://sante.gouv.fr/soins-et-maladies/maladies/maladies-infectieuses/coronavirus/vaccin-covid-19/article/la-strategie-de-vaccination-contre-le-covid-19
2023
false
false
false
France
coronavirus infections
pneumonia, viral
popular works
preventive immunization/medication
vaccination
vaccination
Vaccins
vaccination, nos
Vaccinia
pandemics
viral vaccines
COVID-19
COVID-19 Vaccines

---
https://publications.msss.gouv.qc.ca/msss/document-002830/
2023
false
false
false
Canada
coronavirus infections
pneumonia, viral
scientific and technical information
Examination Questions
social networks
social support
Vaccins
vaccination
preventive immunization/medication
social work
intention
social networking
vaccination
health services
mass vaccination
vaccination, nos
Vaccinia
community networks
health personnel
vaccination
health services
pandemics
viral vaccines
COVID-19
COVID-19 Vaccines

---
https://publications.msss.gouv.qc.ca/msss/document-002140/
2023
false
false
false
Canada
popular works
immunization
quebec
influenza, nos
health
health personnel
Program
Examination Questions
Intertrochanteric fracture
vaccination, nos
immunization programs
intention
influenza, human
immunization
health

---
https://publications.msss.gouv.qc.ca/msss/document-002648/
2023
false
false
false
Canada
quebec
Invasive Streptococcus pneumoniae disease (disorder)
immunization schedule
infant
10-valent pneumococcal vaccine
13-valent pneumococcal vaccine
Asplenia
hemoglobinopathies
hematopoietic stem cell transplantation
scientific and technical information
pneumococcal infections
vaccination
child
immunization programs
adult
pneumococcal vaccines
vaccination
pneumococcal vaccines

---
http://publications.msss.gouv.qc.ca/msss/document-001468/
2023
false
false
false
France
French
patient education handout
scientific and technical information
twinrix
hepatitis b vaccination
preventive immunization/medication
intention
viral hepatitis
immunization programs
schools
medial
Examination Questions
hepatitis B vaccines
hepatitis B
Examination Questions
hepatitis B
hepatitis A vaccines
vaccines, combined

---
http://publications.msss.gouv.qc.ca/msss/document-001243/
2023
false
false
false
false
Canada
French
scientific and technical information
vaccination
papillomavirus vaccines
papillomavirus infections
safety management
immunization programs
quebec
immunization schedule
homosexuality, male

---
https://ansm.sante.fr/tableau-marr/teriflunomide
2023
false
false
false
France
French
administration, oral
risk reduction
patients guideline
handbooks
pregnancy
teratogens
teriflunomide
risk management
contraception
Contraindications, Drug
breast feeding
Chemical and Drug Induced Liver Injury
continuity of patient care
multiple sclerosis, relapsing-remitting
leukopenia
hypertension
opportunistic infections
teriflunomide
crotonates
toluidines
crotonates
toluidines

---
https://ansm.sante.fr/tableau-marr/emicizumab
2023
false
false
false
France
French
emicizumab
risk management
thromboembolism
hemorrhage
thrombotic microangiopathies
blood coagulation tests
risk
hemorrhage
hemophilia A
patients guideline
guidelines for drug use
handbooks
Drug-Related side effects and adverse reactions
injections, subcutaneous
emicizumab
antibodies, bispecific
antibodies, monoclonal, humanized

---
https://ansm.sante.fr/tableau-marr/rituximab
2023
false
false
false
France
French
risk management
Rituximab
Rituximab
infusions, intravenous
injections, subcutaneous
rituximab
guidelines for drug use
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
patient education handout
drug compounding

---
https://ansm.sante.fr/tableau-marr/rituximab-1
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
infusions, intravenous
rituximab
medication errors
guidelines for drug use
patient education handout
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring

---
https://ansm.sante.fr/tableau-marr/rituximab-2
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
infusions, intravenous
rituximab
leukoencephalopathy, progressive multifocal
Infections
medication errors
continuity of patient care

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1319
2023
France
public health guidelines
Water
drinking water
mass vaccination
vaccination, nos
potable water
Water Scarcity
comoros
mayotte
water
judgment
Water
vaccination
Vaccins
vaccination
Vaccinia
preventive immunization/medication

---
https://www.inrs.fr/media.html?refINRS=TM%2075
2023
France
journal article
carcinogens
Allergy
hypersensitivity reaction, nos
adolescent
hypersensitivity

---
https://www.has-sante.fr/jcms/p_3402381/fr/humira-adalimumab-maladie-de-crohn-chez-les-adolescents-et-enfants-6-ans
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
adalimumab
injections, subcutaneous
evaluation of the transparency committee
crohn disease
Adalimumab
child
adolescent

---
https://www.has-sante.fr/jcms/p_3403614/fr/dilatrane-theophylline-asthme-et-bpco
2023
false
false
false
France
insurance, health, reimbursement
administration, oral
capsules
Delayed-Action preparations
asthma
pulmonary disease, chronic obstructive
bronchodilator agents
theophylline
evaluation of the transparency committee
theophylline

---
https://www.ema.europa.eu/en/medicines/human/EPAR/ebvallo
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Tabelecleucel
Tabelecleucel
orphan drug production
adult
child
adolescent
EBV-Related Post-Transplant Lymphoproliferative Disorder
transplantation
lymphoproliferative disorders
injections, intravenous
epstein-barr virus infections
Antineoplastic Agents, Immunological
product surveillance, postmarketing
immunotherapy, adoptive
lymphocyte transfusion
pregnancy
breast feeding
drug evaluation, preclinical
t-lymphocytes
tabelecleucel

---
https://ansm.sante.fr/actualites/decision-du-17-01-2023-renouvellement-du-cpc-de-remicade-100-mg-poudre-pour-solution-a-diluer-pour-perfusion-et-des-specialites-identifiees-comme-biologiques-similaires
https://ansm.sante.fr/tableau-acces-derogatoire/remicade-et-lensemble-des-specialites-biologiques-similaires-dinfliximab
2023
false
false
false
France
French
legislation
Infliximab
takayasu arteritis

---
https://www.ceredih.fr/uploads/CEREDIH_RECO_ANTIBIO_2022_12_16.pdf
2023
France
scientific and technical information
amoxicillin-potassium clavulanate combination
Cefpodoxime
cefpodoxime
has patient
immunologic deficiency syndromes
France
bactrim
cefpodoxime
clamoxyl
France
France
patients
disease
clavulanic acid
france
augmentin
research report
french
albumin/globulin ratio
Cefpodoxime Proxetil
tension
France
amoxycillin with clavulanate potassium
Primary Immunodeficiency Diseases
amoxicillin
primary immune deficiency disorder, nos

---
https://www.academie-medecine.fr/18-janvier-2023-webinaire-les-vaccinations-3e-webinaire-interacademique-franco-marocain/
2023
France
congresses
audiovisual material
preventive immunization/medication
vaccination
Vaccins
vaccinia, nos
vaccinia
vaccines
vaccination, nos
vaccine, nos
vaccination
Vaccinia

---
https://www.has-sante.fr/jcms/p_3406124/fr/tecentriq-atezolizumab-cancer-bronchique-non-a-petites-cellules-cbnpc
2023
false
false
false
France
evaluation of the transparency committee
Tecentriq
neoplasm, malignant
"u" lymphocyte
cancer
atezolizumab
due to
Cancer
atezolizumab
bronchus, nos
Cell
carcinoma, non-small-cell lung
cells

---
PUBLIÉ LE 25/01/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-22-12-2022-au-19-01-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://www.santepubliquefrance.fr/presse/2023/face-a-la-circulation-active-de-virus-grippaux-la-campagne-de-vaccination-contre-la-grippe-saisonniere-est-prolongee-jusqu-au-28-fevrier-2023
2023
France
popular works
influenza vaccination
influenza, human
Vaccins
activir
vaccinia virus
influenza vaccines
long
mass vaccination
face
Viruses
influenza
vaccinia virus
Influenza
preventive immunization/medication
vaccination
virus activation
Vaccinia
Virus

---
https://www.has-sante.fr/jcms/p_3407522/fr/yescarta-axicabtagene-ciloleucel-lymphome-folliculaire
2023
false
false
false
France
lymphoma, follicular
treatment outcome
insurance, health, reimbursement
adult
Refractory Follicular Lymphoma
Recurrent Follicular Lymphoma
infusions, intravenous
axicabtagene ciloleucel
evaluation of the transparency committee
axicabtagene ciloleucel

---
https://www.has-sante.fr/jcms/p_3407525/fr/enbrel-etanercept-immunosuppresseur
2023
false
false
false
France
insurance, health, reimbursement
evaluation of the transparency committee
immunosuppressive agents
Etanercept

---
https://sante.gouv.fr/IMG/pdf/annexe_1_-_dgs_urgent_2023-05.pdf
2023
France
public health guidelines
Paxlovid
effects of exposure to external cause, nos
target population
judgment
health services needs and demand
population groups
Pre-Exposure Prophylaxis
prophylactic treatment, nos
Evusheld

---
https://www.has-sante.fr/jcms/p_3409207/fr/repevax-vaccin-diphterique-tetanique-coquelucheux-acellulaire-multicompose-et-poliomyelitique-inactive-adsorbe-a-teneur-reduite-en-anti-genes
2023
false
false
false
France
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3409198/fr/hexyon-vaccin-diphterique-d-tetanique-t-coque-lucheux-acellulaire-multicompose-ca-de-l-hepatite-b-adnr-hepb-poliomyelitique-inactive-p-et-de-l-haemophilus-influenzae-type-b-hib-conjugue-adsorbe
2023
false
false
false
France
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3409391/fr/revaxis-vaccin-diphterique-tetanique-poliomyelitique-inactive-adsorbe
2023
France
evaluation of the transparency committee
Vaccinia
Diphtheria
poliovirus vaccines
poliomyelitis
tetany, nos
poliomyelitis vaccination
vaccination
poliomyelitis
preventive immunization/medication
Vaccins
Tetany
diphtheria, nos
diphtheria-tetanus vaccine

---
https://www.has-sante.fr/jcms/p_3409204/fr/tetravac-acellulaire-vaccin-diphterique-tetanique-coquelucheux-acellulaire-poliomyelitique-inactive-adsorbe
2023
France
evaluation of the transparency committee
preventive immunization/medication
tetany, nos
Tetany
pertussis
vaccine, nos
diphtheria-tetanus vaccine
Diphtheria
Vaccins
vaccination
whooping cough
poliomyelitis
Whooping cough
whooping cough
diphtheria, nos
Vaccinia
vaccines, acellular
poliomyelitis

---
https://ansm.sante.fr/dossiers-thematiques/covid-19-suivi-hebdomadaire-des-cas-deffets-indesirables-des-vaccins
2023
false
false
false
France
French
drug information
COVID-19
COVID-19 Vaccines
vaccination
anaphylaxis
Drug-Related side effects and adverse reactions
Covid-19 vaccines

---
https://www.has-sante.fr/jcms/p_3410976/fr/kesimpta-ofatumumab-sclerose-en-plaques
2023
false
false
false
France
withdrawing treatment
Medication set-up education, guidance, and counseling (procedure)
ofatumumab
injections, subcutaneous
evaluation of the transparency committee
ofatumumab
multiple sclerosis, relapsing-remitting

---
https://www.has-sante.fr/jcms/p_3410988/fr/ponvory-ponesimod-sclerose-en-plaques
2023
false
false
false
France
administration, oral
ponesimod
withdrawing treatment
Medication set-up education, guidance, and counseling (procedure)
evaluation of the transparency committee
multiple sclerosis, relapsing-remitting
ponesimod

---
https://www.has-sante.fr/jcms/p_3411520/fr/xevudy-sotrovimab-covid-19
2023
false
false
false
France
adult
adolescent
infusions, intravenous
sotrovimab
evaluation of the transparency committee
COVID-19
sotrovimab

---
https://publication-theses.unistra.fr/public/theses_exercice/MED/2022/2022_PARMENTIER_Claire.pdf
2023
France
dissertations, academic
medicine
information processing
vaccination, nos
delivery, obstetric
child
vaccination
vaccination
parental notification
Child
vaccines
Child
parents
vaccine, nos
child, nos
preventive immunization/medication
Child
Vaccins
Electronic Data Processing
physicians
general practitioners
Child
Physicians
vaccinia, nos
vaccinia
Vaccinia
elderly parents
state medicine
general practice
parental age

---
https://ansm.sante.fr/tableau-acces-derogatoire/atgam-50-mg-ml-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
antilymphocyte serum
Equine Thymocyte Immune Globulin
acquired aplastic anemia
drug information
antilymphocyte immunoglobulin (horse)

---
https://www.ema.europa.eu/en/medicines/human/EPAR/spevigo
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
spesolimab
spesolimab
spesolimab
psoriasis
Generalized pustular psoriasis
interleukin-36 receptor, human
adult
infusions, intravenous
product surveillance, postmarketing
aged
pregnancy
breast feeding
drug evaluation, preclinical
drug approval
europe

---
https://www.has-sante.fr/jcms/p_3411128/fr/tedopi-her2-neu-cea-p53-mage-2-mage-3-cbnpc
2023
false
false
false
France
cancer vaccines
HLA-A2 antigen
Multi-neo-epitope Vaccine OSE 2101
evaluation of the transparency committee
carcinoma, non-small-cell lung

---
https://www.has-sante.fr/jcms/p_3413299/fr/vabysmo-faricimab-oedeme-maculaire-diabetique-omd
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
faricimab
faricimab
intravitreal injections
adult
macular edema
diabetic retinopathy
vision disorders
angiogenesis inhibitors
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3417245/fr/strategie-de-vaccination-contre-la-covid-19-anticipation-des-campagnes-de-vaccination-en-2023
2023
France
public health guidelines
vaccination, nos
COVID-19
COVID-19 Vaccines
mass vaccination
preventive immunization/medication
Vaccins
health planning guidelines
vaccination
Vaccinia
vaccination

---
PUBLIÉ LE 27/02/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-13-01-2023-au-16-02-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
mRNA vaccine
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://www.canada.ca/fr/sante-publique/services/publications/vie-saine/guide-canadien-immunisation-partie-1-information-cle-immunisation/page-15-contenu-agents-immunisants-utilises-canada.html
2023
false
false
false
Canada
scientific and technical information
immunization
canada
vaccination, nos
Handbook

---
https://www.academie-medecine.fr/la-voie-de-signalisation-de-sting-dans-les-lymphocytes-t-applications-potentielles-en-immunotherapie-anticancereuse/
2023
France
journal article
t-lymphocytes
Immunotherapy
t lymphocyte
immunotherapy
attention
Applications
Applications
antineoplastic agents
Applications
immunotherapy, nos

---
https://www.has-sante.fr/jcms/p_3418585/fr/yescarta-axicabtagene-ciloleucel-lymphome-ldgcb-lhgcb
2023
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
insurance, health, reimbursement
treatment outcome
Recurrent High Grade B-Cell Lymphoma
lymphoma, large B-Cell, diffuse
Refractory High Grade B-Cell Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
adult
infusions, intravenous
gene therapy
axicabtagene ciloleucel

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-2-3-fevrier-mars-2023/utilite-outil-autodeclaration-test-antigenique-rapide-covid-19-peterborough.html
2023
Canada
journal article
blood group antigen jn a
blood group antigen a.m.
blood group antigen le s
blood group antigen jr a
blood group antigen jo a
blood group antigen re a
blood group antigen mo a
blood group antigen tr a
blood group antigen kn a
blood group antigen wd a
blood group antigen mcc a
blood group antigen bp a
blood group antigen yt a
blood group antigen sf a
blood group antigen os a
blood group antigen lw a
blood group antigen gy a
blood group antigen es a
blood group antigen chr a
blood group antigen lu a
blood group antigen hg a
blood group antigen li a
blood group antigen vg a
health
blood group antigen tg a
blood group antigen pr a
blood group antigen ht a
blood group antigen m1a
blood group antigen a3
blood group antigen le b
blood group antigen a.m.
blood group antigen xg a
blood group antigen le d
blood group antigen au a
blood group antigen le bh
blood group antigen s1a
blood group antigen c
blood group antigen rd a
blood group antigen a1 le b
blood group antigen er a
blood group antigen fr a
blood group antigen fy a
blood group antigen cs a
tool, nos
blood group antigen a2
blood group antigen wk a
blood group antigen pt a
blood group antigen rb a
blood group antigen lan
blood group antigen wr a
blood group antigen sk a
blood group antigen dh a
organization and administration
blood group antigen ri a
blood group antigen ch a
blood group antigen zt a
blood group antigen le c
blood group antigen in a
blood group antigen th a
antigens
blood group antigen dr a
blood group antigen sd a
blood group antigen co a
blood group antigen mt a
blood group antigen en akt
blood group antigen jc a
blood group antigen ok a
blood group antigen en afr
blood group antigen nijhuis
antigen, nos
blood group antigen ol a
blood group antigen kp a
blood group antigen a1 le d
blood group antigen bg a
blood group antigen a2b
blood group antigen a x
blood group antigen jk a
blood group antigen di a
blood group antigen c
blood group antigen le bl
blood group antigen or a
blood group antigen an a
blood group antigen r1a
blood group antigen to a
blood group antigen je a
Antigens
blood group antigen yk a
blood group antigen en afs
blood group antigen vr
blood group antigen cr3
blood group antigen le ns
blood group antigen bx a
blood group antigen sc2
blood group antigen le a
blood group antigen yh a
blood group antigen do a
blood group antigen tj a
blood group antigen lw b
blood group antigen cl a
blood group antigen rh42
COVID-19 Testing
blood group antigen en ats
blood group antigen ls a
blood group antigen sw a
blood group antigen go a
blood group antigen a3b
blood group antigen at a
blood group antigen m'
blood group antigen u1a
blood group antigen js a
blood group antigen m a
blood group antigen st a
blood group antigen a1b
blood group antigen rg a
blood group antigen n a
blood group antigen mi a
blood group antigen pr a
blood group antigen 'n'
blood group antigen be a
blood group antigen rh a
blood group antigen le x
COVID-19
blood group antigen ny a

---
https://lecmg.fr/wp-content/uploads/2023/03/Memo-vaccin-25-CMG-2023.pdf
2023
France
scientific and technical information
Practice
dataset
methacryloxypropyltrimethoxysilane
Vaccinia
preventive immunization/medication
vaccination
Vaccins
vaccines, synthetic
vaccination, nos

---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-manon-barchewitz
2023
France
audiovisual aids
blood group antigen en afs
blood group antigen u1a
blood group antigen rd a
blood group antigen a3
blood group antigen nijhuis
blood group antigen rh a
blood group antigen a x
blood group antigen di a
blood group antigen cr3
blood group antigen vg a
blood group antigen zt a
Economics
blood group antigen rb a
blood group antigen ch a
blood group antigen do a
blood group antigen wr a
blood group antigen es a
blood group antigen vr
blood group antigen tg a
blood group antigen sd a
Perception
blood group antigen c
blood group antigen a1 le b
blood group antigen a1b
blood group antigen at a
blood group antigen mi a
blood group antigen pr a
blood group antigen mo a
blood group antigen cl a
blood group antigen jk a
blood group antigen a.m.
commerce
Perception
blood group antigen wd a
perception
blood group antigen en akt
blood group antigen le c
blood group antigen m'
prices
blood group antigen a3b
blood group antigen rh42
blood group antigen a.m.
blood group antigen a2
blood group antigen le ns
blood group antigen fy a
blood group antigen le a
perception, nos
Patient Engagement
blood group antigen le x
blood group antigen pt a
blood group antigen ht a
cost savings
blood group antigen m1a
blood group antigen a2b
blood group antigen au a
blood group antigen wk a
blood group antigen ok a
blood group antigen 'n'
blood group antigen an a
blood group antigen jo a
blood group antigen yh a
blood group antigen jr a
patients
blood group antigen re a
blood group antigen tr a
awards and prizes
blood group antigen chr a
blood group antigen sk a
blood group antigen tj a
blood group antigen n a
blood group antigen dr a
economics
blood group antigen st a
blood group antigen rg a
blood group antigen sc2
blood group antigen hg a
drug costs
cost analysis
blood group antigen pr a
blood group antigen fr a
blood group antigen je a
blood group antigen kn a
blood group antigen le bl
blood group antigen bp a
blood group antigen dh a
blood group antigen to a
blood group antigen c
blood group antigen xg a
blood group antigen os a
has patient
antigen, nos
blood group antigen yt a
blood group antigen js a
blood group antigen ls a
patient participation
blood group antigen gy a
blood group antigen le d
blood group antigen le bh
blood group antigen mcc a
blood group antigen bg a
blood group antigen en afr
Economy
blood group antigen ny a
blood group antigen en ats
blood group antigen mt a
blood group antigen er a
blood group antigen go a
blood group antigen a1 le d
blood group antigen sw a
blood group antigen lu a
blood group antigen ol a
Antigens
blood group antigen or a
blood group antigen s1a
blood group antigen yk a
blood group antigen kp a
drug, nos
blood group antigen le b
blood group antigen co a
health
antigens
blood group antigen li a
blood group antigen bx a
blood group antigen in a
blood group antigen m a
blood group antigen lw a
blood group antigen r1a
blood group antigen ri a
blood group antigen jn a
blood group antigen sf a
blood group antigen be a
blood group antigen le s
blood group antigen lan
blood group antigen th a
blood group antigen lw b
blood group antigen jc a
blood group antigen cs a

---
https://www.has-sante.fr/jcms/p_3421374/fr/tavneos-avacopan
2023
false
false
false
France
insurance, health, reimbursement
adult
avacopan
drug therapy, combination
Granulomatosis with Polyangiitis
microscopic polyangiitis
Rituximab
cyclophosphamide
treatment outcome
evaluation of the transparency committee
avacopan

---
https://www.has-sante.fr/jcms/p_3419176/fr/yescarta-axicabtagene-ciloleucel-lymphome-diffus-a-grandes-cellules-b-ldgcb-et-lymphome-de-haut-grade-a-cellules-b-lhgcb
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
axicabtagene ciloleucel
axicabtagene ciloleucel
infusions, intravenous
Recurrent Diffuse Large B-Cell Lymphoma
lymphoma, large B-Cell, diffuse
Refractory Diffuse Large B-Cell Lymphoma
Recurrent High Grade B-Cell Lymphoma
Refractory High Grade B-Cell Lymphoma
adult

---
https://www.has-sante.fr/jcms/p_3422332/fr/jakavi-ruxolitinib-maladie-du-greffon
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
adolescent
graft vs host disease
acute disease
chronic disease
Steroid Refractory Graft Versus Host Disease
ruxolitinib
drug resistance
Chronic Graft Versus Host Disease
Acute Graft Versus Host Disease
administration, oral
evaluation of the transparency committee
ruxolitinib

---
https://www.has-sante.fr/jcms/p_3422860/fr/bimzelx-bimekizumab-psoriasis-en-plaques
2023
false
false
false
France
bimekizumab
treatment outcome
insurance, health, reimbursement
adult
injections, subcutaneous
evaluation of the transparency committee
bimekizumab
psoriasis

---
https://ansm.sante.fr/tableau-acces-derogatoire/jakavi-5-mg-comprime
2023
false
false
false
France
French
insurance, health, reimbursement
ruxolitinib phosphate
ruxolitinib
administration, oral
drug information
graft vs host disease
drug resistance
Steroid Refractory Graft Versus Host Disease
acute disease
chronic disease

---
https://conseil-scientifique.public.lu/fr/publications/examens-laboratoire/le-diagnostic-biologique-d-allergologie.html
2023
false
false
false
Luxembourg
guideline
allergy and immunology
clinical laboratory techniques

---
https://ansm.sante.fr/tableau-marr/upadacitinib
2023
false
false
false
France
French
risk management
upadacitinib
patient education handout
guidelines for drug use
upadacitinib
Drug-Related side effects and adverse reactions
administration, oral
upadacitinib
Janus Kinase Inhibitors
Janus Kinase Inhibitors
teratogens
pregnancy
continuity of patient care
herpes zoster
tuberculosis
neoplasms
embolism and thrombosis
Virus Reactivation

---
https://apps.who.int/iris/handle/10665/366577
2023
false
false
false
Switzerland
journal article
blood group antigen m1a
blood group antigen hg a
blood group antigen pr a
genetta, nos
blood group antigen ok a
blood group antigen r1a
blood group antigen sd a
blood group antigen jk a
blood group antigen kp a
Genetics
blood group antigen fr a
blood group antigen at a
blood group antigen yh a
blood group antigen tg a
blood group antigen fy a
blood group antigen jc a
blood group antigen en ats
Viruses
blood group antigen le d
blood group antigen u1a
blood group antigen a.m.
blood group antigen ch a
blood group antigen sf a
blood group antigen cr3
blood group antigen li a
blood group antigen lan
blood group antigen in a
blood group antigen co a
blood group antigen tr a
antigen, nos
blood group antigen lu a
blood group antigen go a
blood group antigen th a
blood group antigen bp a
blood group antigen ht a
blood group antigen en afs
blood group antigen kn a
antigens
blood group antigen pt a
blood group antigen dh a
blood group antigen chr a
blood group antigen or a
blood group antigen jr a
genets
cytisus
Antigens
blood group antigen wk a
due to
blood group antigen pr a
blood group antigen ny a
blood group antigen s1a
blood group antigen dr a
blood group antigen cl a
blood group antigen le x
blood group antigen os a
blood group antigen bg a
blood group antigen le a
Genetics
blood group antigen c
blood group antigen en afr
blood group antigen le c
blood group antigen au a
viverridae
blood group antigen a1 le d
blood group antigen en akt
blood group antigen le b
blood group antigen sk a
blood group antigen rg a
blood group antigen yt a
blood group antigen a1b
blood group antigen vr
blood group antigen le bh
blood group antigen rd a
blood group antigen a1 le b
blood group antigen a.m.
blood group antigen le s
Virus
viruses
blood group antigen sc2
blood group antigen ls a
blood group antigen a2b
blood group antigen to a
Preparation
blood group antigen n a
blood group antigen an a
blood group antigen lw b
blood group antigen ol a
blood group antigen vg a
gene, nos
blood group antigen sw a
blood group antigen jo a
blood group antigen cs a
blood group antigen ri a
blood group antigen wd a
blood group antigen do a
blood group antigen m a
blood group antigen er a
blood group antigen es a
blood group antigen rb a
blood group antigen a3b
blood group antigen wr a
blood group antigen zt a
blood group antigen di a
blood group antigen mi a
blood group antigen lw a
blood group antigen nijhuis
blood group antigen bx a
Genetics
blood group antigen st a
blood group antigen be a
blood group antigen re a
blood group antigen mt a
blood group antigen mo a
blood group antigen xg a
blood group antigen yk a
blood group antigen c
virus, nos
pandemics
blood group antigen rh a
blood group antigen a3
blood group antigen gy a
blood group antigen 'n'
blood group antigen jn a
blood group antigen js a
blood group antigen mcc a
blood group antigen a2
blood group antigen rh42
blood group antigen a x
blood group antigen le ns
blood group antigen m'
blood group antigen je a
blood group antigen tj a
blood group antigen le bl
genetics

---
https://www.has-sante.fr/jcms/p_3424347/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2
2023
false
false
false
France
Metastatic HER2-Positive Breast Carcinoma
Refractory HER2-Positive Breast Carcinoma
Unresectable HER2-Positive Breast Carcinoma
Antineoplastic Agents, Immunological
receptor, erbB-2
treatment outcome
insurance, health, reimbursement
adult
trastuzumab deruxtecan
infusions, intravenous
evaluation of the transparency committee
breast neoplasms
Trastuzumab
trastuzumab deruxtecan

---
https://www.has-sante.fr/jcms/p_3424344/fr/tecvayli-teclistamab-myelome-multiple
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Triple-Class Refractory Multiple Myeloma
adult
antibodies, monoclonal
Teclistamab
injections, subcutaneous
Antineoplastic Agents, Immunological
teclistamab
evaluation of the transparency committee
multiple myeloma

---
https://www.has-sante.fr/jcms/p_3424045/fr/adcetris-brentuximab-vedotine-lymphome-anaplasique-a-grandes-cellules-systemique-lagcs
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
antineoplastic combined chemotherapy protocols
cyclophosphamide
doxorubicin
prednisone
CHP-Brentuximab Vedotin Regimen
Systemic Anaplastic Large Cell Lymphoma, ALK-Negative
Antineoplastic Agents, Immunological
brentuximab vedotin
evaluation of the transparency committee
lymphoma, large-cell, anaplastic
Brentuximab Vedotin

---
PUBLIÉ LE 31/03/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-10-02-2023-au-16-03-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://www.minerva-ebp.be/FR/Article/2312
2023
Belgium
critical appraisal or critical reading
asthma
rehabilitation therapy, nos
rehabilitation centers
rehabilitation
pulmonary rehabilitation
asthma, nos
patient care management
systolic pressure
pulmonaria
Asthma
lung, nos
role
asthma

---
https://www.minerva-ebp.be/FR/Article/2313
2023
Belgium
critical appraisal or critical reading
benzodiazepines
vertigo, nos
benzodiazepine, nos
causation
antihistamine, nos
patients
has patient
high pitch
efficiency
causality
Vertigo
histamine antagonists
vertigo

---
https://apps.who.int/iris/handle/10665/366674
2023
Switzerland
journal article
vaccinia virus vaccine
vaccines
vaccination
Researches
research
group processes
vaccination
advisory committees
Vaccins
Vaccinia
preventive immunization/medication

---
https://www.academie-medecine.fr/vaccinations-obligatoires-des-soignants-lhonneur-dune-profession/
2023
France
scientific and technical information
caregivers
vaccinia, nos
vaccination
occupations
has provider
preventive immunization/medication
vaccination
vaccinia
vaccines
Vaccins
vaccine, nos
occupation, nos
vaccination, nos
Vaccinia

---
https://www.inserm.fr/dossier/immunotherapie-cancers/
2023
France
popular works
Diseases
Immunotherapy
immunotherapy
Systemic disease
immunotherapy, nos
disease of immune system, nos
immune system diseases

---
https://ansm.sante.fr/tableau-marr/rituximab-3
2023
false
false
false
France
French
guidelines for drug use
patient education handout
Rituximab
Rituximab

---
https://ansm.sante.fr/actualites/les-enfants-exposes-a-lhydroxychloroquine-pendant-la-grossesse-de-leur-mere-courent-un-risque-plus-eleve-de-malformation-grave-a-la-naissance
2023
false
false
false
France
French
abnormalities, drug-induced
teratogens
pharmacovigilance note
pregnancy
hydroxychloroquine
risk
patient education handout
In Utero Drug Exposure
antirheumatic agents

---
https://www.has-sante.fr/jcms/p_3425784/fr/propionate-de-fluticasone/salmeterol-eg-airmaster-salmeterol/propionate-de-fluticasone-asthme-et-bpco
2023
France
evaluation of the transparency committee
asthma
Fluticasone
propionate
asthma, nos
Fluticasone Propionate
Asthma
pulmonary disease, chronic obstructive
asthma
chronic obstructive lung disease, nos

---
https://www.has-sante.fr/jcms/p_3426145/fr/humira-adalimumab-psoriasis-en-plaques-chez-l-enfant-et-adolescent
2023
France
evaluation of the transparency committee
Adalimumab
adalimumab
Adolescent
adolescence
Psoriasis
Adolescent
child
Child
psoriasis vulgaris
Child
psoriasis
Child
Child
bone plates
humira
child, nos
adolescent

---
https://www.has-sante.fr/jcms/p_3426154/fr/enbrel-etanercept-psoriasis-en-plaques-chez-l-enfant-et-l-adolescent
2023
false
false
false
France
etanercept
-
evaluation of the transparency committee
child
Etanercept
psoriasis
adolescent

---
https://sante.public.lu/fr/actualites/2023/04/vaccin-contre-zona.html
2023
Luxembourg
popular works
preventive immunization/medication
Set, Psychology
immunocompromised host
vaccine, nos
device, nos
Herpes zoster
vaccination
herpes zoster
Vaccinia
aged, 80 and over
herpes zoster, nos
aged
herpes zoster vaccine
devices
Vaccins
immunodeficiency, nos
age more than 65 years
elderly person, nos

---
https://www.has-sante.fr/jcms/p_3427080/fr/softacort-phosphate-sodique-d-hydrocortisone-inflammation-oculaire
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
conjunctivitis, allergic
Noninfective conjunctivitis
administration, ophthalmic
hydrocortisone
anti-inflammatory agents
conjunctivitis
evaluation of the transparency committee
hydrocortisone
hydrocortisone sodium phosphate

---
https://ansm.sante.fr/tableau-acces-derogatoire/m-m-rvaxpro-priorix
2023
false
false
false
France
French
vaccination
infant
drug information
measles-mumps-rubella vaccine
Post-Exposure prophylaxis
measles

---
https://ansm.sante.fr/tableau-marr/daratumumab
2023
false
false
false
France
French
guideline
patient education handout
risk management
daratumumab
daratumumab
Laboratory test related to immunohematology (procedure)
Laboratory test interference
immunologic tests
hematologic tests

---
https://ansm.sante.fr/tableau-marr/axicabtagene-ciloleucel
2023
false
false
false
France
French
risk management
axicabtagene ciloleucel
guidelines for drug use
axicabtagene ciloleucel
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
nervous system diseases
patient education handout
signs and symptoms
axicabtagene ciloleucel
infusions, intravenous
gene therapy

---
https://ansm.sante.fr/tableau-acces-derogatoire/velcade-1-mg-poudre-pour-solution-injectable
2023
false
false
false
France
French
drug information
Bortezomib
injections, intravenous
Immunoglobulin Light-chain Amyloidosis
Non-amyloid monoclonal immunoglobulin deposition disease

---
https://ansm.sante.fr/tableau-acces-derogatoire/xalkori
2023
false
false
false
France
French
drug information
administration, oral
Crizotinib
antineoplastic agents
protein kinase inhibitors
capsules
pharmaceutical solutions
child
infant
lymphoma, large-cell, anaplastic
Childhood Anaplastic Large Cell Lymphoma, ALK-Positive
crizotinib
MET Exon 14 Mutation
Locally Advanced Lung Non-Small Cell Carcinoma
adult
Metastatic Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
continuity of patient care

---
https://cps.ca/fr/documents/position/asthme-leger
2023
France
practice guideline
child, preschool
Advanced Glycation End Product
Adolescents
Offspring
Asthma Pathway
Adolescent
asthma
child, nos
adolescence
Charge
adolescent
age, nos
asthma
Preschool
asthma, nos
Preschool Completion
patient care management
Very Mild Hallucination
Subject Age
Teenager
Elderly
Asthma
Borg Category-Ratio 10 Perceived Exertion Score 1
Child
Borg Scale Rating of Perceived Exertion Score 9

---
https://www.cfp.ca/content/69/12/833
2023
Canada
journal article
Therapeutic Procedure
Individualized
Epidermal cGVHD Score 2
Slight
asthma, nos
Asthma
Mild Hallucination
asthma
disease
Strategy
Patient
Treatment
has patient
postman
Asthma Pathway
Mild Dysplasia
therapeutics
Personalized
Therapeutic
Mild Adverse Event
patients
asthma

---
http://www.rst-sante-travail.fr/rst/pages-article/ArticleRST.html?ref=RST.TF%20313
2023
France
journal article
Insecta
Have Allergy
Preventive Intervention
animal husbandry
insect, nos
Prevention Study
Implementation
hypersensitivity
hypersensitivity reaction, nos
Insect
Allergic Reaction
Prevention

---
https://sante.gouv.fr/IMG/pdf/presentation_et_utilisation_du_vaccin_nuvaxovid_xbb_1_5.pdf
2023
false
false
false
France
French
guideline
drug compounding
COVID-19 Vaccines
adult
adolescent
COVID-19
vaccination

---
https://www.has-sante.fr/jcms/p_3479047/fr/rinvoq-upadacitinib-maladie-de-crohn-active-moderee-a-severe-chez-les-patients-adultes
2023
false
false
false
France
treatment outcome
Delayed-Action preparations
upadacitinib
Janus Kinase Inhibitors
insurance, health, reimbursement
evaluation of the transparency committee
crohn disease
adult
upadacitinib

---
https://www.has-sante.fr/jcms/p_3427083/fr/imbruvica-ibrutinib-leucemie-lymphoide-chronique-llc
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
Ibrutinib/Venetoclax Regimen
venetoclax
TP53 Gene Mutation Negative
del(17p) Negative
evaluation of the transparency committee
leukemia, lymphocytic, chronic, B-Cell
ibrutinib

---
https://ansm.sante.fr/tableau-marr/adrenaline
2023
false
false
false
France
French
risk management
guidelines for drug use
epinephrine
epinephrine
Self injection
self administration
patient education handout

---
https://www.has-sante.fr/jcms/p_3428384/fr/xalkori-crizotinib-lymphome-t-anaplasique-a-grandes-cellules-lagc-pediatrie
2023
false
false
false
France
child
treatment outcome
insurance, health, reimbursement
antineoplastic agents
crizotinib
guidelines for drug use
administration, oral
Childhood Anaplastic Large Cell Lymphoma, ALK-Positive
recurrence
protein kinase inhibitors
evaluation of the transparency committee
lymphoma, large-cell, anaplastic
Crizotinib

---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-16-03-2023-au-13-04-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://publications.msss.gouv.qc.ca/msss/document-003571/
2023
Canada
popular works
herpes zoster
vaccination, nos
consumer health information
herpes zoster, nos
Examination Questions
health
immunization
immunization programs
health personnel
Herpes zoster
intention
Program
herpes zoster

---
https://www.has-sante.fr/jcms/p_3430182/fr/rybrevant-amivantamab-cancer-bronchique
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
Antineoplastic Agents, Immunological
amivantamab
advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations
carcinoma, non-small-cell lung
Activating EGFR Exon 20 Mutation
evaluation of the transparency committee
amivantamab-vmjw
carcinoma, non-small-cell lung

---
https://www.has-sante.fr/jcms/p_3427913/fr/soliris-eculizumab-syndrome-hemolytique-et-uremique-atypique-shua
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
eculizumab
infusions, intravenous
adult
child
evaluation of the transparency committee
Atypical Hemolytic Uremic Syndrome
eculizumab

---
https://www.has-sante.fr/jcms/p_3430422/fr/mabthera-rituximab-pemphigus-vulgaris-pv-modere-a-severe
2023
false
false
false
France
infusions, intravenous
treatment outcome
insurance, health, reimbursement
rituximab
pemphigus vulgaris
adult
immunologic factors
drug therapy, combination
evaluation of the transparency committee
Rituximab

---
https://ansm.sante.fr/informations-de-securite/simulect-10-mg-et-simulect-20-mg-poudre-et-solvant-pour-solution-injectable-ou-pour-perfusion-ne-pas-utiliser-les-ampoules-de-solvant-eau-pour-preparations-injectables-eau-ppi-conditionnees-avec-les-flacons
2023
false
false
false
France
French
pharmacovigilance note

---
https://www.has-sante.fr/jcms/p_3431815/fr/cutaquig-immunoglobuline-humaine-normale-deficits-immunitaires-primitifs-et-secondaires
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
child
adolescent
injections, subcutaneous
immunoglobulins, normal human, for extravascular adm.
evaluation of the transparency committee
immunologic deficiency syndromes
immunoglobulins
Primary Immunodeficiency Diseases
primary immune deficiency disorder, nos
secondary immune deficiency disorder, nos

---
https://ansm.sante.fr/tableau-marr/faricimab
2023
false
false
false
France
French
risk management
faricimab
risk
patient education handout
faricimab
intravitreal injections
Drug-Related side effects and adverse reactions
signs and symptoms
wet macular degeneration
diabetic retinopathy
Macular edema due to diabetes mellitus (disorder)
patients guideline
sound

---
http://beh.santepubliquefrance.fr/beh/2023/8/2023_8_1.html
2023
France
journal article
malpractice
Epidemiology
france
epidemiology
France
France
hypertension
Epidemiology
Epidemiology
France
population
hypersensitivity
Epidemiology
hypertensive disease, nos
Hypertension
french
Epidemiology
prevalence
France

---
https://www.has-sante.fr/jcms/p_3434154/fr/telfast-chlorhydrate-de-fexofenadine-rhinite-allergique-saisonniere-et-prurit-au-cours-de-l-urticaire-chronique
2023
false
false
false
France
-
-
insurance, health, reimbursement
evaluation of the transparency committee
fexofenadine hydrochloride
fexofenadine

---
https://www.has-sante.fr/jcms/p_3434489/fr/ilumetri-tildrakizumab-psoriasis-en-plaques
2023
false
false
false
France
evaluation of the transparency committee
tildrakizumab
psoriasis

---
https://ansm.sante.fr/informations-de-securite/attention-au-risque-derreur-medicamenteuse-de-surdose-accidentelle-avec-la-nouvelle-pipette-de-theralene
2023
false
false
false
France
French
medication errors
pharmacovigilance note
trimeprazine
pharmaceutical solutions
administration, oral

---
PUBLIÉ LE 17/05/2023
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-13-04-2023-au-11-05-2023
2023
false
false
false
France
French
mRNA Vaccine
mRNA Vaccines
NVX-CoV2373 adjuvated lipid nanoparticle
summary of product characteristics
package leaflet
drug information
pharmacovigilance
adverse drug reaction reporting systems
france
vaccination
Drug-Related side effects and adverse reactions
drug monitoring
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (procedure)
Covid-19 vaccines
COVID-19
COVID-19 Vaccines

---
https://www.has-sante.fr/jcms/p_3442461/fr/xalkori-crizotinib-tumeurs-myofibroblastiques-inflammatoires-tmi
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
Crizotinib
crizotinib
Inflammatory Myofibroblastic Tumor
antineoplastic agents
protein kinase inhibitors
child
adolescent
Childhood Inflammatory Myofibroblastic Tumor
soft tissue neoplasms
ALK Positive
administration, oral

---
https://www.has-sante.fr/jcms/p_3443746/fr/vaxigriptetra-virus-de-la-grippe-fragmente-inactive-vaccin-antigrippal
2023
France
evaluation of the transparency committee
influenza virus vaccine
vaccines, inactivated
Vaccinia
Vaccins
influenza, human
influenza, nos
influenza
viruses
fragmentation, nos
influenza vaccines
preventive immunization/medication
vaccination
Influenza
Virus
virus, nos
Viruses

---
https://www.has-sante.fr/jcms/pprd_2983345/fr/fluarixtetra-vaccin-grippal-quadrivalent-inactive-a-virion-fragmente
2023
France
evaluation of the transparency committee
Quadrivalent Influenza Vaccine
vaccines, inactivated
Vaccins
preventive immunization/medication
vaccine, nos
virion
vaccination
fragmentation, nos
Vaccinia

---
https://www.has-sante.fr/jcms/p_3443743/fr/influvac-tetra-antigenes-de-surface-de-virus-de-la-grippe-inactive-vaccin-antigrippal
2023
France
evaluation of the transparency committee
influvac
vaccination
antigens, surface
Antigens
Vaccins
Vaccinia
Quadrivalent Influenza Vaccine
vaccine, nos
vaccines, inactivated
preventive immunization/medication
hepatitis surface antigen
influvac

---
https://www.has-sante.fr/jcms/p_3443740/fr/fluenz-tetra-virus-grippal-reassorti-vivant-attenue-vaccin-antigrippal
2023
France
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3443734/fr/flucelvax-tetra-vaccin-grippal-quadrivalent-inactive-prepare-sur-cultures-cellulaires-vaccin-antigrippal
2023
France
evaluation of the transparency committee
influenza virus vaccine
Vaccinia
vaccines, inactivated
cell, nos
Vaccins
cell culture techniques
Preparation
preventive immunization/medication
Quadrivalent Influenza Vaccine
vaccination
influenza vaccines

---
https://www.has-sante.fr/jcms/p_3444098/fr/uplizna-inebilizumab-neuromyelite-optique
2023
false
false
false
France
neuromyelitis optica spectrum disorders who are anti-aquaporin 4 antibody positive
treatment outcome
insurance, health, reimbursement
inebilizumab
adult
Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies
Anti-aquaporin 4 antibody positivity
evaluation of the transparency committee
inebilizumab
neuromyelitis optica

---
https://www.has-sante.fr/jcms/p_3443949/fr/hemlibra-emicizumab-hemophilie-a
2023
false
false
false
France
emicizumab
treatment outcome
insurance, health, reimbursement
hemorrhage
guidelines for drug use
evaluation of the transparency committee
hemophilia A
emicizumab

---
https://ansm.sante.fr/dossiers-thematiques/vaccins-contre-les-infections-a-papillomavirus-humains-hpv
2023
false
false
false
France
French
drug information
papillomavirus vaccines
papillomavirus infections
vaccine potency
papillomavirus vaccines
france
papillomavirus vaccines

---
https://www.ema.europa.eu/en/medicines/human/EPAR/enjaymo
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
sutimlimab
sutimlimab
sutimlimab
orphan drug production
cold agglutinin disease
anemia, hemolytic, autoimmune
adult
infusions, intravenous
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3331921/fr/mesure-de-la-fraction-expiree-du-monoxyde-d-azote-feno-pour-l-ajustement-du-traitement-de-l-asthme
2023
France
health technology assessment
asthma
exhalation
weights and measures
asthma, nos
measures
Asthma
adjustment, nos
nitric oxide
nitric oxide
expiration
asthma

---
https://www.has-sante.fr/jcms/p_3445064/fr/triumeq-abacavir/dolutegravir-sodique/lamivudine-vih
2023
false
false
false
France
HIV-1
treatment outcome
insurance, health, reimbursement
administration, oral
adult
adolescent
child
hiv infections
lamivudine
drug combinations
abacavir sulfate
dolutegravir sodium
lamivudine, abacavir and dolutegravir
anti-hiv agents
abacavir, dolutegravir, and lamivudine drug combination
evaluation of the transparency committee

---
https://www.inspq.qc.ca/publications/3339
2023
Canada
public health guidelines
Serogroup
immunization programs
neisseria meningitidis, serogroup y
meningococcal infections
Vaccinia
meningococcus vaccination
Vaccins
neisseria meningitidis, serogroup C
vaccination
infectious disease, nos
preventive immunization/medication

---
https://www.has-sante.fr/jcms/p_3444785/fr/xalkori-crizotinib-lymphome-anaplasique-a-grandes-cellules-lagc
2023
false
false
false
France
French
treatment outcome
child
insurance, health, reimbursement
administration, oral
Crizotinib
crizotinib
evaluation of the transparency committee
adolescent
Refractory Systemic Anaplastic Large Cell Lymphoma, ALK-Positive
Recurrent Systemic Anaplastic Large Cell Lymphoma, ALK-Positive
antineoplastic agents
protein kinase inhibitors
lymphoma, large-cell, anaplastic

---
https://www.has-sante.fr/jcms/p_3444788/fr/enhertu-trastuzumab-deruxtecan-cancer-du-sein-her2-faible
2023
false
false
false
France
French
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
trastuzumab deruxtecan
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
breast neoplasms
neoplasm metastasis
Metastatic HER2-Low Breast Carcinoma
adult
Unresectable Breast Carcinoma
HER2/Neu Low Expression
infusions, intravenous

---
https://www.cbip.be/fr/articles/4098?folia=4095
2023
false
false
false
Belgium
French
journal article
Immunosuppression Therapy
immunosuppressive agents
neoplasms
graft rejection
organ transplantation
risk
risk assessment
neoplasms

---
https://www.has-sante.fr/jcms/p_3447827/fr/rybrevant-amivantamab-cancer-bronchique
2023
France
evaluation of the transparency committee
rybrevant
amivantamab-vmjw
amivantamab-vmjw
bronchial neoplasms
neoplasm, malignant
Cancer
cancer
bronchus, nos

---
https://www.has-sante.fr/jcms/p_3444489/fr/interet-des-tests-rapides-d-orientation-diagnostique-trod-antigeniques-covid/grippe-et-covid/grippe/vrs-en-ville
2023
France
health technology assessment
blood group antigen be a
blood group antigen cl a
blood group antigen n a
blood group antigen c
blood group antigen mcc a
blood group antigen in a
blood group antigen at a
blood group antigen wd a
blood group antigen rg a
blood group antigen lan
blood group antigen sw a
blood group antigen a.m.
blood group antigen lw a
blood group antigen ny a
blood group antigen fy a
blood group antigen an a
blood group antigen en ats
blood group antigen en afs
blood group antigen le bh
blood group antigen a1 le b
blood group antigen en afr
blood group antigen ht a
blood group antigen dh a
blood group antigen er a
blood group antigen ol a
blood group antigen ri a
blood group antigen tr a
blood group antigen m'
blood group antigen a.m.
blood group antigen js a
blood group antigen sk a
blood group antigen th a
blood group antigen rd a
blood group antigen a2
blood group antigen a3
orientation
blood group antigen mi a
blood group antigen sf a
blood group antigen jo a
blood group antigen u1a
blood group antigen je a
blood group antigen wk a
blood group antigen yt a
blood group antigen ls a
blood group antigen c
blood group antigen go a
blood group antigen rh42
blood group antigen vr
blood group antigen wr a
blood group antigen cs a
blood group antigen a x
blood group antigen r1a
blood group antigen a1 le d
blood group antigen sd a
blood group antigen jc a
blood group antigen chr a
blood group antigen sc2
blood group antigen le a
blood group antigen fr a
blood group antigen le b
blood group antigen dr a
blood group antigen jn a
blood group antigen le x
blood group antigen a3b
blood group antigen es a
blood group antigen m a
blood group antigen rh a
blood group antigen bx a
blood group antigen rb a
Antigens
blood group antigen ok a
antigens
blood group antigen xg a
blood group antigen ch a
blood group antigen yk a
blood group antigen cr3
blood group antigen bp a
blood group antigen jk a
blood group antigen mo a
blood group antigen or a
blood group antigen pt a
blood group antigen gy a
diagnostic tests
reagent kits, diagnostic
blood group antigen 'n'
blood group antigen jr a
blood group antigen do a
antigen, nos
blood group antigen st a
blood group antigen mt a
blood group antigen hg a
blood group antigen to a
blood group antigen vg a
blood group antigen lu a
blood group antigen kp a
blood group antigen au a
blood group antigen pr a
blood group antigen lw b
blood group antigen kn a
blood group antigen a2b
blood group antigen co a
blood group antigen re a
blood group antigen le c
blood group antigen le s
blood group antigen di a
blood group antigen zt a
blood group antigen li a
blood group antigen pr a
blood group antigen yh a
blood group antigen tj a
blood group antigen en akt
blood group antigen le ns
working diagnosis
blood group antigen s1a
blood group antigen le d
blood group antigen nijhuis
blood group antigen a1b
blood group antigen tg a
blood group antigen le bl
blood group antigen os a
blood group antigen bg a
blood group antigen m1a

---
https://www.has-sante.fr/jcms/p_3446078/fr/diprosone-betamethasone-/-diprosalic-betamethasone-/-acide-salicylique-corticoides
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
administration, cutaneous
evaluation of the transparency committee
salicylic acid
corticoids
betamethasone
glucocorticoids

---
https://www.has-sante.fr/jcms/p_3447489/fr/ebvallo-tabelecleucel-hemopathie-maligne
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Tabelecleucel
Adoptive Cell Therapy Agent
adult
child
adolescent
EBV-Related Post-Transplant Lymphoproliferative Disorder
Refractory Neoplastic Post-Transplant Lymphoproliferative Disorder
Recurrent Neoplastic Post-Transplant Lymphoproliferative Disorder
tabelecleucel
evaluation of the transparency committee
Malignant hemopathy
hematologic neoplasms

---
https://ansm.sante.fr/tableau-acces-derogatoire/ebvallo
2023
false
false
false
France
French
drug information
Tabelecleucel

---
http://www.lecrat.eu/?s=Canakinumab+-+Grossesse+et+allaitement
2023
false
false
false
France
French
drug information
pregnancy
breast feeding
canakinumab

---
https://www.has-sante.fr/jcms/p_3447364/fr/hemlibra-emicizumab-hemophilie-a-deficit-congenital-en-facteur-viii
2023
false
false
false
France
French
insurance, health, reimbursement
treatment outcome
emicizumab
hemophilia A
hemorrhage
emicizumab
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3447972/fr/typhim-vi-vaccin-typhoidique-polyosidique-fievre-typhoide
2023
false
false
false
France
evaluation of the transparency committee
Polysaccharides
preventive immunization/medication
typhim vi
typhoid vaccine
Vi polysaccharide vaccine, typhoid
typhoid vaccination
Vi polysaccharide vaccine, typhoid
typhoid fever
Vaccins
typhoid-paratyphoid vaccines
vaccination
typhoid fever
fever
Vaccinia
polysaccharides
Typhoid
Fever

---
Nous contacter.
30/04/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.